BiotechTube
Home/Diakonos Oncology/Jay Hartenbach
JH

Jay Hartenbach

President, COO

Diakonos Oncology

Therapeutic Areas

Oncology

Diakonos Oncology Pipeline

DrugIndicationPhase
DOC1021Glioblastoma (GBM)Phase 2

Leadership Team at Diakonos Oncology

MW
Mike Wicks, MS
CEO and Board Member
DF
Dan Faust
Chairman
LA
Laura Aguilar, MD PhD
CMO
DR
Donna Rill
CTO
WD
Will Decker, PhD
CSO
View full Diakonos Oncology profile